Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users.

Major M, Gutfraind A, Shekhtman L, Cui Q, Kachko A, Cotler SJ, Hajarizadeh B, Sacks-Davis R, Page K, Boodram B, Dahari H.

Global Infectious Disease Threats Hepatitis C

Pathways to the elimination of hepatitis C: prioritising access for all.

Pedrana AE, Sacks-Davis R, Doyle JS, Hellard ME

Eliminating HIV/HCV co-infection in gay and bisexual men: is it achievable through scaling up treatment?

Sacks-Davis R, Pedrana AE, Scott N, Doyle JS, Hellard ME

Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access.

Scott N, Hainsworth SW, Sacks-Davis R, Pedrana A, Doyle J, Wade A, Hellard M

Achieving hepatitis C elimination in Europe - To treatment scale-up and beyond.

Hellard M, Scott N, Sacks-Davis R, Pedrana A

Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men.

Bradshaw D, Raghwani J, Jacka B, Sacks-Davis R, Lamoury F, Down I, Prestage G, Applegate TL, Hellard M, Sasadeusz J, Dore GJ, Pybus OG, Matthews GV, Danta M